Elopag-50mg-Eltrombopag

Name: Elopag-50mg-Eltrombopag
Brand: Meds For Cancer
SKU: 2201
Price: 130 USD
Availability: InStock

Elopag-50mg-Eltrombopag is a medication used to treat chronic immune thrombocytopenia in adult and children above 12 years old. Thrombocytopenia is a disease where bone marrow stops producing blood cells that cause lower blood platelet counts. It is also used to treat chronic hepatitis-C. Elopag also can be used in combination with other medication to treat leukemia.

Mechanism of Action of Elopag-50mg-Eltrombopag

Elopag works by stimulating bone marrow to produce more blood platelet that helps in treating thrombocytopenia. By stimulating bone marrow it helps to produce more red blood cells for that platelet is also increased.

Dosage and administration of Elopag-50mg-Eltrombopag:

For Chronic immune thrombocytopenia (ITP): The typical initial dose is 50mg once daily. It can be exceptional based on your platelet count response, your healthcare provider may adjust the dosage in every 2 weeks. It can be 25mg to 50mg, up to a maximum dose of 75mg once daily.
For Chronic hepatitis C-associated thrombocytopenia: The usual starting dose is 50mg once daily. Depending on your platelet count response, your healthcare provider may adjust the dosage in every 2 weeks. It can be of 25mg or 50mg, up to a maximum dose of 100mg once daily.

Elopag 50mg side effects

A medicine may cause some unwanted side effects, which may require medical attention. Common side effects include

bloating,
swelling,
body pain,
difficulty breathing,
fever,
headache,
loss of voice,
chest pain.

Less common side effects include

bladder pain,
blindness,
blurred vision,
itching,
numbness,
diarrhea,
and general discomfort.

These side effects may go away during treatment as the body adjusts to the medicine. Health care professionals may also provide information on preventing or reducing these side effects. If any side effects persist or are bothersome, consult with your doctor if you have any questions or concerns.

Elopag 50mg price

Elopag comes in 2 varients Elopag 25mg and Elopag 50mg. Elopag 25 mg costs $120 and Elopag 50mg costs about $200.

Elopag in Dengue

One of the critical problems during dengue fever is loosing blood platelets rapidly. Sometimes patient immune system and bone marrow can not produce sufficient amount of platelet that patient needs. Where Elopag plays a vital role in producing new blood platelets. Besides this Elopag is also used in treating aplastic anemia which is also a rare blood disorder disease.

See our other Products, bevixa Elbonix-25, Avalet-20mg, Palbonix100/125mg, Ventoxen-100mg, Ibruxen-140mg.

FAQs about Elopag-50mg:

Q: What is Elopag-50mg-Eltrombopag?

A: Elopag-50mg-Eltrombopag is a medication containing the active ingredient Eltrombopag. It is prescribed to stimulate platelet production in individuals with conditions such as chronic immune thrombocytopenia (ITP) or chronic hepatitis C-associated thrombocytopenia.

Q: How does Elopag work?

A: Elopag-50mg-Eltrombopag works by interacting with the body’s natural processes to stimulate the production of platelets in the bone marrow. It helps increase platelet counts, reducing the risk of bleeding and improving clotting ability.

Q: How long does it take for Elopag to show results?

A: The timeframe for experiencing noticeable results may vary among individuals. Some patients may see an improvement in platelet counts within a few weeks of starting Elopag-50mg-Eltrombopag, while others may require a longer duration. It is essential to continue taking the medication as prescribed and follow up with your healthcare provider for monitoring and adjustments.

Q: Are there any side effects associated with Elopag?

A: Like any medication, Elopag-50mg-Eltrombopag may have potential side effects. Common side effects may include nausea, headache, fatigue, muscle or joint pain, and changes in liver function tests. However, not everyone experiences these side effects. It is important to discuss any concerns or unexpected symptoms with your healthcare provider.